 Flosequinan vasodilator positive inotropic activity Flosequinan oral arterial venous vasodilator investigation treatment congestive heart failure effects flosequinan ventricular performance myocardial contractility patients severe congestive heart failure right cardiac catheterization Sixty minutes mg oral dose flosequinan peak rate rise left ventricular pressure dP/dt mm Hg/sec ventricular end-diastolic pressure mm Hg cardiac index mean pulmonary artery pressure vascular resistance mm Hg Heart rate aortic pressure right atrial pressure systemic vascular resistance serum norepinephrine levels increase left ventricular peak dP/dt concomitant decrease left ventricular end-diastolic pressure change systemic arterial pressure sympathetic tone argue direct positive inotropic effect flosequinan